Lisa H Butterfield Selected Research

Lisa H Butterfield Research Topics

Disease

102	Neoplasms (Cancer) 01/2022 - 02/2002
49	Melanoma (Melanoma, Malignant) 01/2022 - 11/2002
13	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 02/2002
11	Glioma (Gliomas) 01/2022 - 12/2007
10	Liver Neoplasms (Liver Cancer) 01/2019 - 02/2002
3	Fatigue 01/2020 - 05/2010
3	Squamous Cell Carcinoma of Head and Neck 04/2017 - 06/2012
3	Neoplasm Metastasis (Metastasis) 12/2015 - 11/2014
2	Brain Neoplasms (Brain Tumor) 01/2022 - 12/2020
2	Testicular Neoplasms (Testicular Cancer) 01/2018 - 01/2014
2	Head and Neck Neoplasms (Head and Neck Cancer) 04/2017 - 05/2014
2	Carcinoma (Carcinomatosis) 01/2016 - 05/2010
2	Colitis 01/2015 - 01/2014
2	Diarrhea 01/2015 - 01/2014
2	Pain (Aches) 06/2011 - 05/2010
2	Experimental Melanoma 04/2011 - 06/2005
2	Hepatitis B 02/2007 - 11/2004
1	Adenocarcinoma 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Vascular Tissue Neoplasms 11/2021
1	Diffuse Intrinsic Pontine Glioma 12/2020
1	Tertiary Lymphoid Structures 01/2020
1	COVID-19 01/2020
1	Genomic Instability 01/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019
1	Nevus (Nevi) 01/2018
1	Hypersensitivity (Allergy) 01/2018

Drug/Important Bio-Agent (IBA)

45	AntigensIBA 01/2022 - 07/2002
39	VaccinesIBA 01/2022 - 11/2002
27	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2003
27	Peptides (Polypeptides)IBA 11/2021 - 07/2002
18	CytokinesIBA 01/2020 - 11/2004
16	Proteins (Proteins, Gene)FDA Link 11/2021 - 07/2002
15	EpitopesIBA 12/2016 - 03/2003
14	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2019 - 12/2003
12	Neoplasm Antigens (Tumor Antigens)IBA 01/2019 - 06/2003
10	InterferonsIBA 11/2021 - 12/2007
9	IpilimumabIBA 01/2022 - 09/2012
8	Cancer VaccinesIBA 12/2020 - 10/2007
6	Protein Subunit VaccinesIBA 01/2018 - 02/2009
6	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2017 - 08/2012
6	HLA-A*02:01 antigenIBA 01/2014 - 03/2003
5	Fetal Proteins (Fetoprotein)IBA 01/2022 - 07/2011
4	HLA Antigens (Human Leukocyte Antigens)IBA 11/2021 - 12/2007
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 10/2011
4	Biological ProductsIBA 01/2019 - 06/2012
4	gallium arsenide (GaAs)IBA 12/2016 - 12/2007
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2017
3	EnzymesIBA 11/2021 - 12/2007
3	Interleukin-2 (IL2)IBA 01/2020 - 07/2008
3	ChemokinesIBA 01/2019 - 10/2011
3	InterleukinsIBA 01/2019 - 12/2007
3	poly ICLCIBA 01/2016 - 01/2011
3	MART-1 AntigenIBA 01/2016 - 09/2003
3	DNA (Deoxyribonucleic Acid)IBA 04/2014 - 06/2003
3	AutoantigensIBA 01/2014 - 02/2002
3	Monophenol Monooxygenase (Tyrosinase)IBA 08/2012 - 04/2008
2	Glycoproteins (Glycoprotein)IBA 01/2022 - 01/2016
2	Programmed Cell Death 1 ReceptorIBA 11/2021 - 01/2017
2	pembrolizumabIBA 01/2021 - 11/2017
2	B7-H1 AntigenIBA 01/2021 - 01/2017
2	LigandsIBA 12/2020 - 11/2018
2	Chimeric Antigen ReceptorsIBA 01/2020 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2019 - 06/2003
2	Monatide (IMS 3015)IBA 09/2017 - 11/2004
2	Pharmaceutical PreparationsIBA 01/2016 - 12/2011
2	Interleukin-10 (Interleukin 10)IBA 01/2015 - 12/2004
2	Lysine (L-Lysine)FDA Link 07/2014 - 01/2011
2	Carboxymethylcellulose Sodium (Polycell)FDA Link 07/2014 - 01/2011
2	Poly I-CIBA 07/2014 - 01/2011
2	HLA-DR Antigens (HLA-DR)IBA 01/2014 - 01/2014
2	Interleukin-12 (IL 12)IBA 04/2011 - 11/2002
2	Viral AntigensIBA 02/2007 - 11/2004
1	Interferon-alpha (Interferon Alfa)IBA 01/2022
1	NivolumabIBA 01/2022
1	sotigalimabIBA 01/2022
1	LipidsIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 11/2021
1	ImmunosorbentsIBA 11/2021
1	Dasatinib (BMS 354825)FDA Link 11/2021
1	dipinacoline glutamateIBA 12/2020
1	Matrix Metalloproteinases (MMPs)IBA 12/2020
1	AntibodiesIBA 01/2020
1	N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2019
1	Viral DNAIBA 01/2019
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2019
1	ACAM2000IBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 12/2018
1	afliberceptIBA 11/2018
1	Interferon Type IIBA 01/2018

Therapy/Procedure

61	Immunotherapy 01/2022 - 02/2002
31	Therapeutics 01/2022 - 08/2004
5	Drug Therapy (Chemotherapy) 01/2022 - 10/2013
5	Biological Therapy 09/2011 - 12/2008
3	Injections 04/2014 - 08/2004
2	Radiotherapy 01/2015 - 12/2007
2	Neoadjuvant Therapy 01/2015 - 06/2012
2	Complementary Therapies (Alternative Medicine) 02/2007 - 11/2004